Terry A Jacobson

9PUBLICATIONS
35CO-AUTHORS
Medical devicesCardiology (incl. cardiovascular diseases)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 22, 2025
Benefit of Icosapent Ethyl Across Types and Sizes of Myocardial Infarction in REDUCE-IT.

Chen Gurevitz, Deepak L Bhatt, Robert P Giugliano

|Dec 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States.

William S Weintraub, Deepak L Bhatt, Zugui Zhang

|Feb 21, 2023
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.

Brian Olshansky, Deepak L Bhatt, Michael Miller

|Aug 11, 2022
Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking.

Michael Miller, Deepak L Bhatt, Ph Gabriel Steg

|Apr 04, 2022
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT.

Senthil Selvaraj, Deepak L Bhatt, Ph Gabriel Steg

|Mar 09, 2022
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.

Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg

Pageof 2